XML 50 R41.htm IDEA: XBRL DOCUMENT
v3.22.1

SCHEDULE OF INVESTMENT (Details) | 3 Months Ended
--- | ---
Mar. 31, 2022 USD ($)
Melt Pharmaceuticals, Inc. [Member] |
Net Investment Income [Line Items] |
Cost basis | $ 19,310,000
Share of Equity Method Losses | (11,063,000)
Paid in Kind Interest | 1,021,000
In Substance Capital Contributions | (1,021,000)
Net carrying value | 8,247,000
Common Stock [Member] | Melt Pharmaceuticals, Inc. [Member] |
Net Investment Income [Line Items] |
Cost basis | 5,810,000
Share of Equity Method Losses | (5,810,000)
Paid in Kind Interest |
Common Stock [Member] | Surface Ophthalmics, Inc. [Member] |
Net Investment Income [Line Items] |
Cost basis | 5,320,000
Share of Equity Method Losses | (5,320,000)
Net carrying value |
Loan [Member] | Melt Pharmaceuticals, Inc. [Member] |
Net Investment Income [Line Items] |
Cost basis | 13,500,000
Share of Equity Method Losses | (5,253,000)
Paid in Kind Interest | 1,021,000
In Substance Capital Contributions | (1,021,000)
Net carrying value | $ 8,247,000

X
- Definition Investment paid in kind interest. + References No definition available. + Details
Name: | HROW_InvestmentPaidInKindInterest
Namespace Prefix: | HROW_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition This element represents the aggregate cost of investments accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_EquityMethodInvestmentAggregateCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of funds committed to investment company from investors. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 205 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=25866437&loc=d3e10491-115837 + Details
Name: | us-gaap_InvestmentCompanyCommittedCapital
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cost of the investment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section 50 -Paragraph 6 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.1(h)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_Investments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=HROW_MeltPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=HROW_SurfaceOphthalmicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=HROW_LoanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |